These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 36096182

  • 1. Current use of bone turnover markers in the management of osteoporosis.
    Brown JP, Don-Wauchope A, Douville P, Albert C, Vasikaran SD.
    Clin Biochem; 2022; 109-110():1-10. PubMed ID: 36096182
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    Williams C, Sapra A.
    ; 2024 01. PubMed ID: 32644732
    [Abstract] [Full Text] [Related]

  • 4. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR.
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [Abstract] [Full Text] [Related]

  • 5. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A.
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [Abstract] [Full Text] [Related]

  • 6. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
    Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET, National Bone Health Alliance Bone Turnover Marker Project.
    Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS, Lylloff L, Rønne MS, Møllehave LT, Heidemann M, Thuesen BH, Johannesen J, Schou AJ, Husby S, Wedderkopp N, Mølgaard C, Jørgensen NR.
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges.
    Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, Myers G, Silverman S, Vesper HW, Lee D, Payette M, Randall S.
    Osteoporos Int; 2012 Oct; 23(10):2425-33. PubMed ID: 22797491
    [Abstract] [Full Text] [Related]

  • 13. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE, Rand MS, Haddock B, Arup S, Smith CD, Jensen JEB, Schwarz P, Hovind P, Oturai PS, Jensen LT, Møller S, Eiken P, Rubin KH, Hitz MF, Abrahamsen B, Jørgensen NR.
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [Abstract] [Full Text] [Related]

  • 14. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z, Jin X, Bian P, Li X, Chen J.
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [Abstract] [Full Text] [Related]

  • 15. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N, Parés A, Alvarez L, Martínez de Osaba MJ, Monegal A, Peris P, Ballesta AM, Rodés J.
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [Abstract] [Full Text] [Related]

  • 16. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM, Hay SM, Bottjer HM, Eastell R.
    Osteoporos Int; 1999 Apr; 10(5):408-15. PubMed ID: 10591839
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-related trends and reference intervals of cross-linked C-telopeptide of type I collagen and procollagen type I N-propeptide from a reference population of Sri Lankan adult women.
    Rathnayake H, Lekamwasam S, Wickramatilake C, De Zoysa E, Lenora J.
    Arch Osteoporos; 2021 Nov 02; 16(1):164. PubMed ID: 34727246
    [Abstract] [Full Text] [Related]

  • 19. Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90.
    Ivaska KK, McGuigan FE, Malmgren L, Gerdhem P, Johansson H, Kanis JA, Akesson KE.
    Calcif Tissue Int; 2022 Sep 02; 111(3):288-299. PubMed ID: 35750934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.